M B Sugars and Pharmaceuticals Private Limited

M B Sugars and Pharmaceuticals Private Limited - pharma in Nashik, Maharashtra, India. FY 2026 financials & compliance.
CIN U15420MH1996PTC096832 Incorporated 02 February 1996 ROC Mumbai HQ Nashik, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹197.48 Cr
▲ 24% YoY
Net profit · FY 2025
₹28.96 Cr
Net margin 14.7%
EBITDA · FY 2025
₹55.34 Cr
EBITDA margin 28%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹73.2 Lakh
Issued & subscribed
Open charges
₹67.35 Cr
Satisfied ₹32.28 Cr
Company age
30 yrs
Est. 1996
Employees · EPFO
201
Provident fund records

About M B Sugars and Pharmaceuticals Private Limited

Data last updated:

M B Sugars and Pharmaceuticals Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 February 1996 and has been in existence for over 30 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U15420MH1996PTC096832. Its GSTIN is 27AABCM2351A1Z3 (Maharashtra).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹73.2 Lakh. It was formerly known as M B Sugars and Pharmaceuticals Limited. It is led by directors including Vijaykumar Bhagchand Lodha (Managing Director) and Dineshkumar Bhagchand Lodha.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lodha Bhavanp B No 31 Malegaon, Nashik, Maharashtra, India – 423203.

As per the financials filed for FY 2025, the company reported a revenue of ₹197.48 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹28.96 Cr (net margin 14.7%) and EBITDA of ₹55.34 Cr (EBITDA margin 28%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 13% over five years.

The company has about 201 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹67.35 Cr and satisfied charges of ₹32.28 Cr on record. Court records list 40 cases involving the company, including 39 filed by the company and 1 filed against it; 19 cases are pending. The company has 7 deals on record (7 secondary share transfers); the latest was in March 2023. The company has 13 MSME Form 1 returns on record between 2019 and 2024, listing 409 overdue payments to 92 micro and small suppliers.

M B Sugars and Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0005979). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mbsugar.com.

Company details

CIN U15420MH1996PTC096832
Registration Number 096832
Incorporation Date 02 February 1996
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-23-0005979

CIN history

M B Sugars and Pharmaceuticals has one previous CIN (Corporate Identification Number): U15420MH1996PLC096832. The current CIN is U15420MH1996PTC096832, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U15420MH1996PTC096832Current
U15420MH1996PLC096832Previous

Recognitions & Rankings of M B Sugars and Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-23-0005979

Contact details

M B Sugars and Pharmaceuticals Private Limited's registered office is in Nashik, Maharashtra. Its website is mbsugar.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Lodha Bhavanp B No 31 Malegaon, Nashik, Maharashtra, India – 423203
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of M B Sugars and Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
M B Sugars and Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of M B Sugars and Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of M B Sugars and Pharmaceuticals Private Limited, buy the company report.

Financials of M B Sugars and Pharmaceuticals Private Limited

FY 2025 filings available

M B Sugars and Pharmaceuticals Private Limited reported revenue of ₹197.48 Cr (up 24% YoY) for FY 2025.

Revenue · FY 2025
₹197.48 Cr ▲ 24%
Net profit · FY 2025
₹28.96 Cr margin 14.7%
EBITDA · FY 2025
₹55.34 Cr margin 28%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 6%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 22%
5 years · compounded
▲ 27%

Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 24% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹55.34 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹28.96 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin28%
Net Profit Margin14.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of M B Sugars and Pharmaceuticals Private Limited, buy the company report.

Board of directors of M B Sugars and Pharmaceuticals Private Limited

M B Sugars and Pharmaceuticals has 6 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Dineshkumar Bhagchand LodhaDirector02 Feb 199630 Years 9 MonthsCurrent
Anilkumar Bhagchand LodhaDirector02 Feb 199630 Years 9 MonthsCurrent
Samyak Vijaykumar LodhaDirector06 Jun 200719 Years 4 MonthsCurrent
Rushabh Anilkumar LodhaDirector01 Apr 200818 Years 7 MonthsCurrent
Vijaykumar Bhagchand LodhaManaging Director02 Feb 199630 Years 9 MonthsCurrent
Saurabh Dineshkumar LodhaDirector14 Mar 20197 Years 7 MonthsCurrent

Auditor

M B Sugars and Pharmaceuticals Private Limited is audited by S S MUTHA & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
S S MUTHA & CO.FY 2023114117W)

Shareholding

The shareholding of M B Sugars and Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of M B Sugars and Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹67.35 Cr
Satisfied charges
₹32.28 Cr
Breakdown by lending institutions
Others₹66.45 Cr
Dbs Bank Ltd₹0.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Aug 2025101146026Others₹15 CrOpen
09 Apr 2024100914009Others₹1.35 CrOpen
09 Apr 2024100917013Others₹1.35 CrOpen
29 Mar 2024100931072Others₹1.35 CrOpen
07 Nov 2023100807482Others₹20 CrOpen

To see the full charge records of M B Sugars and Pharmaceuticals Private Limited, buy the company report.

Total charge records: 23 View all charges

Deals & funding

M B Sugars and Pharmaceuticals Private Limited has 7 deals on record (7 secondary share transfers); the latest was in March 2023.

Total deals
7
Secondary share transfers
7

Deals on record (5 of 7)

WhenDealAmountParties
Mar 2023Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Nov 2022Secondary share transferUndisclosedBuyer: 3 individuals
Seller: an individual
Mar 2022Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Mar 2022Secondary share transferUndisclosedBuyer: 3 individuals
Seller: 4 individuals
Dec 2021Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 3 individuals

To see the full deal history of M B Sugars and Pharmaceuticals Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

M B Sugars and Pharmaceuticals Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 409 overdue payments to 92 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 92)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
an individual supplier
an individual supplier
J.V.A.G. Pharma Consultants

To see the full MSME payment records of M B Sugars and Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

M B Sugars and Pharmaceuticals Private Limited has a workforce of 201 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.

Employee count
201
Active EPFO establishments
1
Employee growth
-4.74%

GST

M B Sugars and Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AABCM2351A1Z3MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of M B Sugars and Pharmaceuticals Private Limited, buy the company report.

Recent activity

M B Sugars and Pharmaceuticals Private Limited has 8 board changes on record since 1996: 7 appointments and 1 cessation. The latest: Saurabh Dineshkumar Lodha was appointed as Director on 14 Mar 2019.

AGM
M B Sugars And Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101146026 was registered on 28 Aug 2025.
Charges
A charge registered on 19 Oct 2022 via Charge ID 100621386 with Others was fully satisfied on 04 Apr 2025.
Charges
A charge registered on 25 Jun 2015 via Charge ID 10591086 with Dbs Bank Ltd was fully satisfied on 04 Apr 2025.
Charges
A charge registered on 25 Jun 2015 via Charge ID 10591084 with Dbs Bank Ltd was fully satisfied on 04 Apr 2025.
Charges
A charge registered on 08 Jan 2020 via Charge ID 100313420 with Others was fully satisfied on 03 Apr 2025.
Filing
M B Sugars And Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 1.35 Cr with Charge ID 100914009 was registered on 09 Apr 2024.
Charges
A charge with Others amounted to Rs. 1.35 Cr with Charge ID 100917013 was registered on 09 Apr 2024.
Charges
A charge with Others amounted to Rs. 1.35 Cr with Charge ID 100931072 was registered on 29 Mar 2024.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100807482 was registered on 07 Nov 2023.
Charges
A charge registered on 22 Oct 2020 via Charge ID 100380914 with Others was fully satisfied on 14 Sep 2023.

46 earlier events are in the company report.

Frequently asked questions

M B Sugars and Pharmaceuticals is an active private limited company based in Nashik, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 February 1996 (30+ years old) and is registered under CIN U15420MH1996PTC096832.

M B Sugars and Pharmaceuticals has 6 current directors:

The latest financial statements of M B Sugars and Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of M B Sugars and Pharmaceuticals is 27AABCM2351A1Z3, registered in Maharashtra.

The CIN (Corporate Identification Number) of M B Sugars and Pharmaceuticals is U15420MH1996PTC096832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

M B Sugars and Pharmaceuticals has 40 court cases on record: 39 filed by the company and 1 filed against it. 19 are pending. Most are in the district courts.

M B Sugars and Pharmaceuticals was incorporated on 02 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Mumbai.

M B Sugars and Pharmaceuticals has 7 deals on record (7 secondary share transfers); the latest was in March 2023.

Saurabh Dineshkumar Lodha was appointed as Director on 14 Mar 2019. Bhagchand Motilal Lodha ceased to be Director on 05 Oct 2014. Rushabh Anilkumar Lodha was appointed as Director on 01 Apr 2008. M B Sugars and Pharmaceuticals has 8 board changes on record in total.

Yes, M B Sugars and Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-23-0005979).

M B Sugars and Pharmaceuticals has 13 MSME Form 1 returns on record between 2019 and 2024, listing 409 overdue payments to 92 micro and small suppliers. The latest return was filed on 29 Apr 2024.